SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-18-000163
Filing Date
2018-11-14
Accepted
2018-11-14 17:09:56
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e1193_form10q.htm 10-Q 426104
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 8545
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 8544
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 4315
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 4316
  Complete submission text file 0001731122-18-000163.txt   2945296

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enob-20180930.xml EX-101.INS 412023
7 XBRL SCHEMA FILE enob-20180930.xsd EX-101.SCH 35394
8 XBRL CALCULATION FILE enob-20180930_cal.xml EX-101.CAL 51892
9 XBRL DEFINITION FILE enob-20180930_def.xml EX-101.DEF 165066
10 XBRL LABEL FILE enob-20180930_lab.xml EX-101.LAB 289646
11 XBRL PRESENTATION FILE enob-20180930_pre.xml EX-101.PRE 240307
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54478 | Film No.: 181185021
SIC: 2834 Pharmaceutical Preparations